Showing results (171-180 of 2,355) with videos related to
Sort By:
Pageof 236
Clinical Neuropharmacology|February 1, 1997
Effect of L-Dopa and the catechol-O-methyltransferase inhibitor Ro 41-0960 on sulfur amino acid metabolites in ratsJ W Miller, B Shukitt-Hale, R Villalobos-Molina, et al.Clinical Neuropharmacology|February 1, 1997
Life-threatening dysphagia following prolonged neuroleptic therapyT Hayashi, T Nishikawa, I Koga, et al.Clinical Neuropharmacology|February 1, 1997
An open-label study of botulinum toxin A for treatment of tardive dystoniaD Tarsy, D Kaufman, K D Sethi, et al.Clinical Neuropharmacology|April 1, 1997
Psychiatric and sexual disorders induced by apomorphine in Parkinson's diseaseE Courty, F Durif, M Zenut, et al.Clinical Neuropharmacology|April 1, 1997
Clozapine in hemiballismus: report of two casesM Stojanovic, N Sternic, V S KosticClinical Neuropharmacology|December 1, 1996
Effects of sodium ozagrel on hemostatic markers and cerebral blood flow in lacunar infarctionM Oishi, Y Mochizuki, M Hara, et al.Clinical Neuropharmacology|December 1, 1996
Postural myoclonus induced by phenytoinJ Duarte, A P Sempere, M C Cabezas, et al.Clinical Neuropharmacology|February 1, 1996
Apomorphine tolerance in Parkinson's disease: lack of a dose effectS T Gancher, W R Woodward, J G NuttClinical Neuropharmacology|April 1, 1995
The stress protein response and its potential relationship to prolonged seizure activityD H LowensteinPageof 236